State Street’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

State Street’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-855,814	Closed	-$28.5M	–	4379
2024 Q3	$28.5M	Buy	855,814 +53,962	+7%	+$1.86M	﹤0.01%	2007
2024 Q2	$21.7M	Buy	801,852 +153,343	+24%	+$3.02M	﹤0.01%	2129
2024 Q1	$14M	Buy	648,509 +350,042	+117%	+$7.63M	﹤0.01%	2381
2023 Q4	$1.8M	Buy	298,467 +4,600	+2%	+$22.9K	﹤0.01%	3345
2023 Q3	$1.63M	Sell	293,867 -618	-0.2%	-$3.98K	﹤0.01%	3406
2023 Q2	$2.16M	Buy	+294,485	New	+$2.23M	﹤0.01%	3378

State Street's LBPH Position: Q4 2024 in Review

State Street sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 855,814 shares — an estimated $28.5M sold.

State Street first reported a position in LBPH in Q2 2023 and held it in 6 quarters. The position peaked at $28.5M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

State Street reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
State Street sold 855,814 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $28.5M.
State Street first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q2 2023 and held it in 6 quarters.
State Street's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $28.5M in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on State Street's 13F filing for Q4 2024, filed 14 Feb 2025.